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Abstract 
The use and abuse of alcohol and nicotine are intimately related, with co-use of alcohol among 
adult cigarette smokers higher (>65%) than non-smokers (>45%), and smoking rates among 
alcoholics above 75%. Smoking is associated with an accelerated progression to alcohol 
dependence, suggesting that nicotine and alcohol act in a synergistic manner to promote co-
abuse. While recent work has begun to identify discrete ‘neuronal ensembles’ within stress and 
reward circuitry components that underlie nicotine’s contribution to escalations in alcohol self-
administration, the neurobiological mechanisms facilitating alcohol-nicotine interactions 
following chronic drug exposure remain understudied. The goal of the current work was to 
identify a network of brain regions in mice that are activated differentially following chronic 
intermittent exposure to alcohol versus alcohol plus nicotine combinations via c-Fos 
immunoreactivity. Male C57BL/6J mice were systemically treated with either alcohol (1.5 g/kg) 
or a combination of alcohol plus nicotine (0.4, 0.8, or 1.2 mg/kg base) on a double-alternation 
schedule (drug, drug, saline, saline) for a 13-month period. Mice were euthanized 90-min 
following the final treatment, whole brains were removed and 40-µm coronal sections were 
evaluated for c-Fos immunoreactivity using established laboratory procedures. Co-administration 
of 0.4 and 0.8 mg/kg nicotine dose-dependently enhanced c-Fos immunoreactivity in the ventral 
tegmental area (VTA), centrally projecting Edinger-Westphal nucleus (cpEW), and the lateral 
septum (LS) when compared to alcohol only treated mice. In contrast, co-administration of 1.2 
mg/kg resulted in a 33% decline in c-Fos labeled cells within the VTA, no change in LS 
activation, and comparable activation to 0.4 mg/kg nicotine in the cpEW. In summary, chronic 
intermittent nicotine exposure exacerbates the c-Fos response to alcohol in a dose-dependent and 
brain region-selective fashion. The nearly uniform, maximal response observed following 0.8 
mg/kg nicotine across stress- and reward-associated brain regions is consistent with the ability of 
this dose to accelerate the progression towards excessive alcohol self-administration and to 
potentiate the discriminative stimulus effects of alcohol in rodents. 
 
-Dedicated to my Dad -
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Introduction  
Alcohol & Nicotine  
The use of Alcohol and Tobacco products has become a major public health 
concern in recent years. Nicotine specifically is the primary component in tobacco 
products that leads to drug dependence and reward. Alcohol and nicotine have 
pharmacological and neurological synergistic effects, resulting in various health problems 
such as cancers, vascular diseases, and gastric ulcers (Hurley, Taylor, & Tizabi, 2012). 
Widespread legalization and abundant availability plays a role in these most commonly 
abused substances, but genetic, rewarding, and analgesic properties of alcohol and 
nicotine also add to massive levels of use among the public. Alcohol and nicotine are 
often used simultaneously, especially among alcoholics, where smoking rates are 
estimated to be about twice as much as the general population in both adolescents and 
adults (Falk, Yi, & Hiller-Sturmhöfel, 2006). This is a growing concern because 
traditional addiction research has only set out to study the effects of alcohol and nicotine 
separate from one another. This approach to addiction research does not accurately 
represent the way in which alcoholics and smokers consume these substances.  In turn, 
the use of alcohol among adult cigarette smokers is relatively high (65.2%) compared to 
non-smokers (48.7%) (CDC, 2013). Acute nicotine administration has also been shown to 
increase alcohol self-administration in non-dependent smokers, suggesting that nicotine 
dose can effect alcohol’s interaction with the brain early in the process of addiction 
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(Barrett, Tichauer, Leyton, & Pihl, 2006). The current research aims to address the 
question of how chronic, long term exposure, to alcohol and nicotine may influence the 
way these drugs are taken over time by creating a novel set of ‘neuronal ensembles’ that 
utilize previously associated mechanisms of addiction. With these questions in mind, 
knowing how various dosing levels of nicotine react with a consistent dose of alcohol can 
aid in finding the neurological mechanisms underlying co-abuse. Nicotine seems to prime 
the reward and stress system for alcohol, resulting in a greater amount of alcohol 
administration, and produces long lasting changes to signaling pathways (Doyon et al., 
2013). It is currently unclear as to how co-morbidity arises from the interaction of these 
two drugs, but further exploration of nicotine addiction can help reveal many aspects of 
drug dependence, especially in adolescents and people with mental illness, who are at 
higher risk for co-morbidity (Dani & Harris, 2005). As a way to incorporate running 
hypotheses within the field of addiction research, the involvement of stress hormones and 
associated stress-hormone releasing structures within the brain are included in the 
analysis of ‘neuronal ensembles’, but it is still under investigation as to how exactly these 
stress pathways are influencing the neurology and behaviors of addiction. Stress-related 
hormones have been found to have lasting changes in dopamine and GABA 
neurotransmission, which are active components of the reward pathway (Walker et al., 
2012). GABA acts primarily as an inhibitory neurotransmitter, with activation typically 
causing a decrease in neuronal excitability in the central nervous system (CNS), with 
notable building evidence to a possible link between the GABA type A (GABAA) 
receptor and the genetic component of alcoholism (Davies, 2003). Alcohol acts partially 
on the GABAA receptors to enhance receptor activity and increasing the amount of 
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GABA available. Dopamine, on the other hand, is associated with all drugs of abuse and 
is commonly associated by researchers with wanting, learning, and reward. The 
relationship between dopamine and other neurotransmitters, especially GABA, is vital to 
understanding the way in which these networks of addiction and reward operate. The 
receptors where nicotine act in the brain are thought to be primarily nicotinic 
acetylcholine receptors (nAChRs), and are involved in both the mediation of  alcohol and 
the cause of  behavioral changes in nicotine (Bito-Onon, Simms, Chatterjee, Holgate, & 
Bartlett, 2011). nAChRs are found in many areas in the brain, including those related to 
reward and stress (Ventral Tegmental Area, Substantia Nigra, Striatum, Hypothalamus). 
Exploration of the basic mechanisms involved in co-abuse are needed before it can be 
fully understood as to how these neurotransmitters, receptors, and pathways are 
interacting with alcohol and nicotine. By studying the overlapping actions of alcohol and 
nicotine, valuable information about the co-abuse of many drugs of addiction can be 
revealed. These efforts lay down the groundwork for further research not only in the field 
of addiction, but for any study of neurological interactions and mechanisms. This 
approach can effectively narrow the direction of how treatments are used and made 
accessible for public use.  
Animal Model of Co-Abuse  
As a way of addressing issues in studying co-abuse, neurological activity must be 
examined to reveal specific areas of the brain that are most active when alcohol and 
nicotine are present. Although substance abuse is a human concern, using a suitable 
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animal model can provide valuable behavioral and neurological data on alcohol-nicotine 
interactions.  It is unlikely that an exact representation of the complexity of human 
addiction can be reached using the animal model alone, but specific aspects can be 
revealed such as drug self administration, tolerance, sensitivity, and withdrawal (Balogh, 
Owens, Butt, Wehner, & Collins, 2002). Procedures of self-administration have shown 
that rats will continually consume significant amounts of both alcohol and nicotine when 
made available, with levels of nicotine self-administration similar to rates of nicotine 
alone (Lê et al., 2010). This research supports the important relationship between the two 
drugs, and the need to use animal models to ask basic questions about how are 
interacting. Animal models can be used as a way to address questions that both fully 
utilize the particular model and maximize results for comparison and analysis.  
Mechanisms of Addiction  
Abused drugs act on a series of neurological mechanisms within the brain, 
specifically the reward system. All individuals use the reward system every day for many 
aspects of life including eating, drinking, sex, and social engagement. The reinforcement 
of behaviors that are beneficial for survival are pleasurable to us because of the function 
of the reward system. We continue to partake in these activities because the neurological 
pathways are strengthened after each interaction, establishing a memory of reward. Drugs 
of addiction utilize the same reward pathways to alter an individual’s natural drive 
towards drug seeking behaviors. Because the brain is communicating via electrical and 
chemical signaling, drugs can change the way in which this signaling process happens, by 
either strengthening or weakening the communication between neurons. The chemical 
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signal used by neurons are called neurotransmitters, and when released, bind to receptors 
that activate a cascade of cellular activity. Dopamine (DA) is the key neurotransmitter 
involved in the reward system, but GABA, glutamate, and serotonin among others are 
also involved. DAergic neurons project from the VTA and midbrain structures to limbic 
and cortical areas, including the Nucleus Accumbens and the Prefrontal Cortex when 
activated by pleasurable stimuli. When dopamine is released in the form of a chemical 
message, it either binds to receptors or is taken back up through transporters reuse. Drugs 
of addiction, such as alcohol and nicotine, indirectly excite the neurons that produce 
dopamine in the VTA to generate a greater amount of dopamine release within the 
synapse. The repeated pulse of dopamine receptor activation will de-sensitize the reward 
system over time, which decreases the normal dopamine response to healthy and 
everyday rewarding activities. When drugs are used often over a long period of time, as 
with chronic drug users, the brain begins to adapt to these changes. A patterned response 
is then established, which is referred to as neuroadaptation. The response from the brain 
is a developed tolerance, where the same doses of the drug no longer produce the same 
effect and larger doses are needed to get the desired gratification. Drugs of addiction will 
quickly rise to a top priority for users with a compromised reward system, because these 
drugs give greater pleasure than other activities. Over time, the dopamine receptors will 
become overstimulated and stop responding to the previous dose of the drug, which 
eventually leads to permanent damages to the way the brain functions in everyday 
activity.  
The stress system adds an additional feature to the way drugs are delivering the 
experience of reward and pleasure. The hypothalamic-pituitary-adrenal (HPA) axis is 
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activated when our body naturally reacts to stress. The hypothalamus is a small structure 
that regulates the release of hormones from the pituitary gland. The release of hormones 
from the pituitary gland travel down the bloodstream to the kidneys and interact with the 
adrenal glands. The regulation of the stress response begins at the hypothalamus, where a 
hormone called corticotropin-releasing hormone (CRH) is released. CRH signals to the 
pituitary gland to secrete adrenocorticotropic hormone (ACTH) into the bloodstream, 
which travels down to the adrenal glands and signals the release of different steroid 
hormones depending on the site of activation. A class of hormones released from the 
outer (cortical) layer of the adrenal glands are called glucocorticoids, specifically cortisol, 
and they play and important role in stress, which increase blood sugar, suppress the 
immune system, and aid metabolism. ACTH also acts on the adrenal medulla (center of 
the adrenal gland) to trigger the release of epinephrine and norepinephrine, thereby 
increasing heart rate and alertness. Elevated cortisol levels in the bloodstream are sensed 
by glucocorticoid receptors in the hypothalamus that initiate a negative feedback 
response to counteract the stress response. This regulation via negative feedback allows 
for the regulation of cortisol to maintained at appropriate levels. Glucocorticoid receptors 
are also found in the midbrain, striatum, and cortical areas important for reward. It has 
been suggested that a nicotine and alcohol combination alters stress hormones in the early 
stages of drug intake and prime the system for negative emotional states, which are 
described as withdrawal (George F. Koob et al., 2014). This further supports the idea that 
having a nicotine addiction (i.e. smoking cigarettes) can make a person more susceptible 
to drinking high amounts of alcohol.  
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Neural Circuitry Underlying Alcohol and Nicotine Effects  
Alcohol (or ethanol specifically) is a dynamic drug that reacts with several brain 
functions. Generally, alcohol is known as a depressant that inhibits brain activity in the 
CNS. Alcohol interacts with GABA-A receptors to gate the amount of negatively charged 
ions (i.e., chloride) that are let into the cell. Chloride acts to inhibit the excitability of the 
neuron by causing hyperpolarization. For drinkers of alcohol, results of the interaction 
with GABA-A receptors produce calming and anxiolytic effects at low doses, but 
negative effects impair judgement and disrupt motor functions at higher doses. NMDA 
(glutamate) receptors, which are associated with the excitability of the neuron, are 
inhibited by alcohol by blocking the gating of sodium (Na+) and calcium (Ca+2) into 
cells. Nicotine is a psychostimulant that acts on acetylcholine receptors (nAChRs) to 
depolarize the neuron and increase excitability. Within the sympathetic nervous system 
nicotine increases blood pressure, heart rate, and the release of norepinephrine. Cigarette 
smokers experience effects of calmness, alertness, relaxation, but negative symptoms of 
craving, irritability, and impatience.  
When these drugs are taken together, both biological and behavioral effects are 
altered. The complex phenotypes that are observed in addicted individuals vary 
depending on the drug(s) of choice, resulting in different neurological changes within 
these circuits. Although neuronal activation following alcohol or nicotine can be 
observed separately, the combination of the two drugs likely alters the way these 
pathways would function during single drug use (for instance, synergism or additivity) or 
involves activation of new pathways in the brain.  To begin to understand how alcohol 
 
 
8 
and nicotine are interacting we must gain a perspective on previous addiction studies, 
findings, and definitions. A commonly accepted addiction model describes three 
progressive stages of the addiction that involve binge, withdrawal, and craving (G. F. 
Koob, 1997). These stages have been associated with discrete circuits that incorporate 
specific neuronal structures that describe how theories of addiction can be applied to a 
variety of drugs.  Ventral tegmental area (VTA) and ventral striatum are associated with 
binge, amygdala with withdrawal, and prefrontal cortex, basolateral amygdala, 
hippocampus, and insula with craving (G F Koob & Volkow, 2010). Response to chronic 
exposure tends to be more restricted within certain brain regions in the case of alcohol. 
On the other hand,  consistent response from both chronic and acute treatments of alcohol 
are seen from lateral septum, edinger-westphal nucleus, and paraventricular nucleus of 
the hypothalamus (Vilpoux, Warnault, Pierrefiche, Daoust, & Naassila, 2009). The use of 
mecamylamine (nACh-R antagonist) or other ligands that bind to receptors activated by 
alcohol or nicotine may allow for a clear view of what types of activity are happening 
with or without this substance.  Nicotine speeds up the process of alcohol drinking in 
dependent rats, recruiting a number of neuronal structures including VTA and 
dorsomedial prefrontal cortex, blocking nicotinic receptors with mecamylamine (non-
competitive antagonist of nAChRs), effectively blocking  behavioral and neuronal effects 
(Leão et al., 2015). Drugs that replace the effects of alcohol or nicotine can help to 
determine what each substance is acting on receptors and interacting with each other. The 
influence of nAChR antagonist mecamylamine has been examined within operant self-
administration in C57BL/6J mice, and found a suppression in dose-dependent alcohol 
intake and change in locomotor activity (Ford et al., 2009). Although more experiments 
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using drug substitutions still need to take place, the previous findings suggest that a map 
of the way in which nAChRs and neuronal activity function with the combination of 
alcohol and nicotine would be of valuable importance for addiction research.  
c-Fos 
C-Fos is the cellular counterpart to a viral gene isolated in 1982 from Finkel-
Biskis-Jinkus osteogenic sarcoma virus, and is defined as a type of immediate-early gene 
(IEG) that rapidly responds to intracellular signaling (Sng, Taniura, & Yoneda, 2004). 
IEGs have been an important focus of the field of addiction research for over 20 years 
because administering drugs of addiction (chronic or acute) changes IEG expression, 
which can be used to measure the processes of addiction in a way that identifies drug-
induced neuroplastic changes (Kalivas et al., 2006). Positive c-Fos activation has been 
identified using immunocytochemistry to reveal effects of nicotine on brain regions 
related to stress, suggesting they could be mediating the effects of nicotine on the central 
nervous system (CNS) (Matta, Valentine, & Sharp, 1997). C-Fos can be stained in the 
brain by using an antibody to reveal the regions activated prior to mice being euthanized. 
We would expect the traditional reward and stress regions to be active, but c-Fos can 
reveal new areas of activation and significant suppression or expression differences in 
varied doses.   
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Research Question  
How does chronic intermittent administration of alcohol and alcohol-nicotine 
combinations change the amount of brain activation in the male C57BL/6J mouse brain?  
Hypothesis  
It was hypothesized that the combined effects of alcohol and nicotine would 
produce brain activation in stress and reward related areas, with the combined alcohol-
nicotine dosing (fixed alcohol dose plus low, medium or high dose nicotine) showing a 
difference in activation compared to the saline or alcohol only control groups.  
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Methods 
C57BL/6J (B6) mice were acquired from the Jackson Laboratory-West 
(Sacramento, CA, USA) for the drug discrimination (behavioral) portion of this study 
(beyond the scope of this thesis; data not shown). All the mice were male, and double 
housed in standard laboratory cages. Lights were turned on from 6am-6pm each day to 
regulate sleep cycles. The mice were given food, and maintained at 90% of their free-
feeding body weights. Water was freely available. The Institutional Animal Care and Use 
Committee (IACUC) approved all procedures with the animals in accordance with state 
and federal guidelines. IACUC members are made up of qualified and experienced 
experts that oversee animal programs, facilities, and procedures (Ford, McCracken, 
Davis, Ryabinin, & Grant, 2012).  
Dosing & Treatment  
Mice groups were administered a fixed alcohol dose (1.5 g/kg) or one of three 
combinations of alcohol + nicotine. Treatment groups were as follows: 1.5 g/kg alcohol 
(1.5E) alone, 1.5 g/kg alcohol + 0.4 mg/kg nicotine (1.5E + 0.4N), 1.5 g/kg + 0.8 mg/kg 
nicotine (1.5E + 0.8 N), and 1.5 g/kg alcohol + 1.2 mg/kg nicotine (1.5E + 1.2N). Fixed 
ratio schedule (FR) was used as a form of operant conditioning that provided 
reinforcement after a specified number of responses. Once the mice were trained, the 
mice were divided into separate groups and given an intraperitoneal (i.p.) injection of 
either the saline, alcohol, or nicotine-alcohol combination (Ford et al., 2012).  A double-
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alternation schedule of drug administration was used where saline (i.e., non-drug) was 
given two days in a row and then alcohol or both drugs for two days (saline, saline, drug, 
drug). Each group of mice were required to meet criteria for drug discrimination for three 
days prior to and including the final testing session, the last requirement that the mice 
needed to demonstrate criteria on the test session that day in order to be euthanized (see 
Ford et al., 2012 for additional details). To avoid disruptions in home cage environments, 
both mice (housed in pairs) were required to meet criteria on the same day. Each group 
(n=12) was divided into sub-groups (n=6) that were balanced with a four day mean 
according to total responses from both levers (activity measure), initial FR accuracy (% 
appropriate responding), and body weight (training sessions only; test sessions not 
included). The time of day, handling, and transportation were all taken in to consideration 
during the procedure for final testing, as to not disrupt normal occurrences in the home 
cage. Individual mice were injected with treatment dose according to sub-group and 
placed into the operant chamber for 10-min pretreatment. Following pretreatment, the 
house light turning on and the test session began for the standard 15 min sessions. The 
mice were then returned to their home cage and fed their daily food diet, and remained in 
the procedural room for another 55 min before being transported to a separate procedural 
room where they were placed in a CO2 chamber. At 90 min total after initial treatment 
injection mice were euthanized (Ford et al., 2012). Normally, a perfusion of 
paraformaldehyde (PFA) is used to preserve the tissue and organs of the mouse, but in 
this particular procedure  PFA was not used because it can prevent the primary antibody 
(c-Fos) from binding properly.  The whole brain was isolated in a time sensitive manner 
(about 12ml of fixative tissue) and placed into a cold a 2% paraformaldehyde buffer. The 
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brains can then be cryoprotected and stored for up to year or more. When brains are ready 
to be sliced they are placed on a fixative mount, covered with a thin layer of Optimal 
Cutting Medium (OCT), and frozen before being cut into slices 30-40 microns thick. 
After the slices are placed into net wells they are stained with the primary antibody (c-
Fos), washed, and dried before coverslipping with cryoseal (Ryabinin, Criado, Henriksen, 
Bloom, & Wilson, 1997). The final product of this procedure allows for the stained brain 
slices to be viewed under a microscope for comparison and analysis.  
Imaging & Counting Cells 
An initial global examination of the mouse brain slides was taken using a light 
microscope and a mouse brain atlas. This allowed for an unbiased look at c-Fos 
activation throughout different sections of the brain. Certain areas with staining that 
could be seen easily with the naked eye stuck out immediately, but it was still difficult to 
get an accurate count of cell activation (ranging from 10-2000 cells) along with having a 
way to to detect the variations in size, shape, and clarity of the stained cells. The 
traditional method for counting cells, done by hand, would not provide a reliable count of 
the cells that were stained on each slide and because some sections contained thousands 
of cells, we needed an accurate way to measure and analyze these cell populations for 
statistical comparison. To best examine each brain slice, digitalized each of the slices 
using a light microscope and a camera (mounted on top). 
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Figure 1: Light Microscope with Mounted Camera  
The camera itself was hooked up to a computer monitor for live viewing of the 
microscope slides. This provided an accurate way to see how the image would turn out 
before taking the shot. The camera settings were kept consistent to preserve uniformity 
between images.  
 This proved to aid in the clarity of the staining along with providing the ability to 
use additional analysis programs. With the help of Andrey Ryabinin’s lab at OHSU 
Marquam Hill we were able to get a series of images from the following brain regions 
including: Lateral Septum (LS), Edinger-Westphal Nucleus (EW), Substantia Nigra 
(SN)(Bi-Lateral), Nucleus Accumbens (NuAcc)(Bi-Lateral), and Ventral Tegmental Area 
(VTA)(Bi-Lateral) (OHSU, n.d.). Beginning with each brain region, settings on the light 
microscope and mounted camera were kept at consistent settings, with a background 
image of blank light taken at the start of each session. The background image would later 
be subtracted from the brain image to reduce any excess light and allow for a clearer view 
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of the staining. The regions of interest (ROIs) were imaged and organized by mouse 
number and slide. To keep the images consistent across regions the light microscope 
would be rented out for 4-8 hours at a time to capture the entire selection. For the 
analysis, ImageJ was used, an open-source java-based processing program developed at 
the National Institutes of Health (NIH) to provide the architecture to create a procedure 
for counting c-Fos cells (ImageJ, n.d.) Each image was properly rotated and examined for 
any obstructive light, dirt, or user interference.  
 
Figure 2: Region of Interest (ROI) ImageJ  
The region above (EW) is an un-edited zoomed-in captured image (10x) of a mouse brain 
slice. Because each slice image needed to be consistent, none of the slides were edited for 
contrast or acuity. This required a great deal of attention to the way in which each image 
was captured.  
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The background image and the ROI image was opened in ImageJ, and the 
background was subtracted. A new black and white ROI image was then generated to 
allow for a noise free analysis of the stained cells. 
  
Figure 3: Subtracted Background Black and White ImageJ 
The purpose of subtracting the background allows for a clear view of the tissue only 
without the noise of the ambient light from the microscope, The black and white image 
allows for a greater contrast to help reveal the stained cell bodies.  
The threshold tool within ImageJ was adjusted to fill up of the cell bodies, and a 
standard threshold criteria was established (10-110 pixels^2). 
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Figure 4: Threshold ImageJ 
The threshold acts as a mask on top of the subtracted background image. The red 
selections can be adjusted until only stained cell bodies are highlighted. During the 
analysis portion the perimeters for each cell size is set to exclude any particles too large 
or small to be a cell.  
A free hand selection method and a mouse brain atlas was used to select the ROI 
within the image to adjust for the size variance between brain slices and regions. After 
selecting the ROI, everything outside the selection was cleared and an analysis of the cell 
particles were run using ImageJ tools. 
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Figure 5: Hand-tool Selection ImageJ 
The mouse brain atlas (Paxinos and Franklin’s 4th Edition) was used to identify the brain 
region stained was consistent with the ROI before making a hand drawn selection around 
the area. Everything outside the selected region is then cleared to make sure outside 
particles are not picked up in the cell count analysis.  
A summary of the cell counts, total region area, and average cell size was 
generated for each slice (3-6 slices per mouse). Statistical data was analyzed using two 
way ANOVA to compare 0.4N, 0.8N, and 1.2N doses to the ethanol only treated group 
and comparisons between individual groups. Averages were obtained by combining all 
slice counts from each mouse (n=5-6 mice per group).   
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Results 
 
 
A 
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Co-administration of 0.4 and 0.8 mg/kg nicotine dose-dependently enhanced c-Fos 
immunoreactivity in the ventral tegmental area (VTA) compared to the ethanol only 
group (Graph A). The VTA is a bilateral structure that was imaged and analyzed on the 
left and right side separately to check for any variance between the two sides, but none 
was found. The centrally projecting Edinger-Westphal nucleus (cpEW) (Graph B), and 
the lateral septum (LS) (Graph C) when compared to alcohol only treated mice also 
displayed an enhanced level of c-Fos activation among the 0.4 and 0.8 mg/kg nicotine 
D 
C 
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groups. The 0.4N and 0.8N groups seem to provide the most dynamic activation among 
the treatment groups, leading to the possibility of using these groups for further studies of 
stress and reward.  In contrast, co-administration of 1.2 mg/kg resulted in a 33% decline 
in c-Fos labeled cells within the VTA, no change in LS activation, and comparable 
activation to 0.4 mg/kg nicotine in the cpEW. These high levels of nicotine may be 
overstimulating the cells in each region, but without knowing which cells in particular are 
activating (i.e neurons vs glia) it is difficult to conclude anything from these decreased 
levels of activation. Chronic intermittent nicotine exposure is altering the c-Fos response 
to alcohol in a dose-dependent and brain region-selective fashion, but these results only 
indicate general cellular activation within the specified regions. To look in more detail at 
the types of cellular activation taking place in these regions we would need to label for 
cell types and receptors that interact with alcohol and nicotine specifically. The nearly 
uniform, maximal response observed following 0.8 mg/kg nicotine across stress- and 
reward-associated brain regions such as the NucAcc (Graph D) is consistent with the 
ability of this dose to accelerate the progression towards excessive alcohol self-
administration and to potentiate the discriminative stimulus effects of alcohol in rodents. 
Low statistical power (n=5-6 mice per group) in this study compared with other studies 
using higher populations of mice (8-12 mice per group) can contribute to the lack of 
significant changes of activation between groups.  
 
 
Conclusions  
Addiction research has come a long way in recent years, with new methods and 
approaches being developed constantly. As we gain a basic understanding of the 
neurobiology of addiction, new questions arise at every turn. Polysubstance abuse, 
particularly the interactions of alcohol and nicotine have major gaps that must be 
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addressed by the scientific community. There is an obvious social concern with rates of 
comorbidity as high as 92% in people with alcohol use disorders (AUDs)  (Gold, 1998). 
The main pharmacotherapeutic strategies do not reflect the way in which drugs are used 
in our society today, but focus on reducing either alcohol or nicotine use separately.   
None of these individual pharmacological options have proven to have the wide success 
that in needed to have any significant impact.  People use drugs of abuse for a large 
variety of reasons and therapies should have a similar kind of a approach to essentially 
tailor to individual needs. The current research has aimed to model a chronic user of both 
alcohol and nicotine. Because of this, subpopulations of drug users at different stages of 
addiction may have an entirely different set of effects, as would be expected. Although 
recognizing the way in which a chronic user is functions can help identifying the discrete 
‘neuronal ensembles’ of activation to seek out and observe in the future.  The types of 
activation found in this study has shown a wide variety of regions that are incorporated 
when both alcohol and nicotine are present, but this could lead to a specific narrative that 
can be linked together. In addition to using knowledge of the reward system recent work 
has incorporated the stress system to aid in piecing together the mechanisms in 
facilitating the escalation of alcohol drinking with chronic nicotine users (Leão et al., 
2015).  With more researchers asking new questions and conducting alternative methods 
to studying addiction the sense of breaking through  the barriers of   past approaches and 
finding useful therapeutic treatments is that much closer to realization. 
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